Human immunodeficiency virus type 1 gp160 and gp41 binding to Candida albicans selectively enhances candidal virulence in vitro

Journal of Infectious Diseases

Volumn 177, Issue 4, 1998, Pages 1057-1063

  Gruber, Andreas ^b   Lukasser Vogl, Elisabeth ^b   Borg Von Zepelin, Margarete ^b   Dierich, Manfred P ^b   Würzner, Reinhard ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTIC PROTEINASE; GLYCOPROTEIN GP 160; GLYCOPROTEIN GP 41;

ARTICLE; CANDIDA ALBICANS; ENZYME ACTIVITY; HUMAN IMMUNODEFICIENCY VIRUS 1; NEUTROPHIL; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; VIRULENCE; YEAST CELL;

EID: 0031958486     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/515231     Document Type: Article

References (15)

1. Klein RS, Harris CA, Small CB, Moll B, Lesser M, Friedland GH. Oral candidiasis in high-risk patients as the initial manifestation of the acquired immunodeficiency syndrome. N Engl J Med 1984;311:354-8.
2. Odds FC. Candida and candidosis. 2nd ed. London: Baillière Tindall, 1988.
3. Cutler JE. Putative virulence factors of Candida albicans. Annu Rev Microbiol 1991:45:187-218.
4. Schmid J, Odds FC, Wiselka MJ, Nicholson KG, Soll DR. Genetic similarity and maintenance of Candida albicans strains from a group of AIDS patients, demonstrated by DNA fingerprinting. J Clin Microbiol 1992;30:935-41.
5. Whelan WL, Kirsch DR, Kwon Chung KJ, Wahl SM, Smith PD. Candida albicans in patients with the acquired immunodeficiency syndrome: absence of a novel or hypervirulent strain. J Infect Dis 1990;162:513-8.
6. Pujol C, Reynes J, Renaud F, et al. The yeast Candida albicans has a clonal mode of reproduction in a population of infected human immunodeficiency virus - positive patients. Proc Natl Acad Sci USA 1993;90:9456-9.
7. Macdonald F, Odds FC. Virulence for mice of a proteinase-secreting strain of Candida albicans and a proteinase-deficient mutant. J Gen Microbiol 1983;129:431-8.
8. De Bernardis F, Agatensi L, Ross IK, et al. Evidence for a role for secreted aspartate proteinase of Candida albicans in vulvovaginal candidiasis. J Infect Dis 1990;161:1276-83.
9. Ollert MW, Wende C, Gorlich M, et al. Increased expression of Candida albicans secretory proteinase, a putative virulence factor, in isolates from human immunodeficiency virus - positive patients. J Clin Microbiol 1995;33:2543-9.
10. De Bernardis F, Chiani P, Ciccozzi M, et al. Elevated aspartic proteinase secretion and experimental pathogenicity of Candida albicans isolates from oral cavities of subjects infected with human immunodeficiency virus. Infect Immun 1996;64:466-71.
11. Wu T, Samaranayake LP, Cao BY, Wang J. In-vitro proteinase production by oral Candida albicans isolates from individuals with and without HIV infection and its attenuation by antimycotic agents. J Med Microbiol 1996;44:311-6.
12. Vartivarian SE. Virulence properties and nonimmune pathogenetic mechanisms of fungi. Clin Infect Dis 1992;14(suppl 1):S30-6.
13. Murphy PM, Lane HC, Fauci AS, Gallin JI. Impairment of neutrophil bactericidal capacity in patients with AIDS. J Infect Dis 1988;158:627-30.
14. Bandres JC, Trial J, Musher DM, Rossen RD. Increased phagocytosis and generation of reactive oxygen products by neutrophils and monocytes of men with stage 1 human immunodeficiency virus infection. J Infect Dis 1993;168:75-83.
15. Quinti I, Palma C, Guerra EC, Gomez MJ, Mezzaroma I, Aiuti F, Cassone A. Proliferative and cytotoxic responses to mannoproteins of Candida albicans by peripheral blood lymphocytes of HIV-infected subjects. Clin Exp Immunol 1991;85:485-92.